What question did this study set out to answer?

The aim is to explore the association of Nogo-B levels with vascular complications in type 2 diabetes and its protective role in endothelial cells.

March 6, 20261 citations

View Full Paper

Levels and Effects of Nogo-B in Patients With Type 2 Diabetes or Hyperglycemic HUVEC Model.

LILaurent IrakozeRepublic of Burundi LMLinqiang MaThe Affiliated Yongchuan Hospital of Chongqing Medical University YGYu GuThe Affiliated Yongchuan Hospital of Chongqing Medical University

Key Points

The aim is to explore the association of Nogo-B levels with vascular complications in type 2 diabetes and its protective role in endothelial cells.
Assessment of Nogo-B levels in T2DM patients
In vitro study using hyperglycemic HUVEC model
Analysis of endothelial cell injury and TGF-β signalling
Lower Nogo-B levels correlate with increased vascular complications in T2DM patients
Nogo-B mitigates endothelial cell injury in hyperglycemic conditions
Alterations in TGF-β signalling are observed with Nogo-B intervention

Abstract

Our study has proved that lower levels of Nogo-B are independently associated with VC in T2DM patients. In an in vitro model, Nogo-B alleviates endothelial cell injury by affecting TGF-β signalling. Further studies are still needed to support or verify our findings.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Irakoze et al. (Sun,) studied this question.

synapsesocial.com/papers/69aa705a531e4c4a9ff5a0f8 https://doi.org/https://doi.org/10.1002/edm2.70188

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI से पूछें

Bookmark

View Full Paper